Companies House true 2024-02-20 2025-02-28 true 15506805 uk-bus:Director1 2024-02-20 2025-02-28 15506805 uk-bus:Director2 2024-02-20 2025-02-28 15506805 2024-02-20 2025-02-28 15506805 2025-02-28 15506805 uk-bus:EntityHasNeverTraded 2024-02-20 2025-02-28 15506805 uk-bus:FRS102 2024-02-20 2025-02-28 15506805 uk-bus:FullAccounts 2024-02-20 2025-02-28 15506805 uk-bus:AuditExempt-NoAccountantsReport 2024-02-20 2025-02-28 15506805 uk-bus:OrdinaryShareClass1 2024-02-20 2025-02-28 15506805 uk-bus:OrdinaryShareClass2 2024-02-20 2025-02-28 15506805 uk-bus:OrdinaryShareClass3 2024-02-20 2025-02-28 15506805 uk-bus:PreferenceShareClass1 2024-02-20 2025-02-28 15506805 uk-bus:PreferenceShareClass2 2024-02-20 2025-02-28 15506805 uk-bus:PreferenceShareClass3 2024-02-20 2025-02-28 15506805 uk-core:ShareCapitalPreferenceShares 2025-02-28 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 15506805

UK FELIX BIOTECHNOLOGY CO., LTD

Dormant Accounts

28 February 2025

UK FELIX BIOTECHNOLOGY CO., LTD Registered Number 15506805

Balance Sheet as at 28 February 2025

2025
£
Current assets
Cash at bank and in hand
500000
Net assets
500000
Issued share capital
500000 Ordinary Shares of £ 1 each 500000
Total Shareholder funds
500000

STATEMENTS

  1. For the year ending 28 February 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 28 February 2025

And signed on their behalf by:
。 ,, Director

NOTES

During the year the company acted as an agent for a person